Variability in the effects of 5-HT-related compounds in experimental models of anxiety: Evidence for multiple mechanisms of 5-HT in anxiety or never ending story?

Polish Journal of Pharmacology

Volumn 48, Issue 2, 1996, Pages 129-136

  Griebel, Guy ^a  

^a SANOFI   (France)

Author keywords

5 HT (serotonin); Animal models; Anxiety; Review

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; ANXIOLYTIC AGENT; BEMESETRON; BUSPIRONE; FLUOXETINE; GEPIRONE; GRANISETRON; ONDANSETRON; RECEPTOR SUBTYPE; RICASETRON; RITANSERIN; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 1C RECEPTOR; SEROTONIN 2A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2C AGONIST; SEROTONIN 2C ANTAGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN RECEPTOR AFFECTING AGENT; SEROTONIN UPTAKE INHIBITOR; TROPISETRON; ZACOPRIDE;

ANIMAL MODEL; ANXIETY NEUROSIS; BEHAVIOR; COMPULSION; EMOTION; ETHOLOGY; NONHUMAN; OBSESSION; REVIEW; SEROTONINERGIC SYSTEM;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN;

EID: 0030017587     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Aprison M. H., Ferster C. B.: Neurochemical correlates of behavior. II. Correlation of brain monoamine oxidase activity with behavioural changes after iproniazid and 5-hydroxytryptophan administration. J. Neurochem., 1961, 6, 350-357.
2. 3 Antagonists and Benzodiazepines. Their Comparative Behavioural Pharmacology. Eds. Rodgers R. J., Cooper S. J., John Wiley & Sons, Chichester, 1991, 59-105.
3. Barrett J. E., Vanover K. E.: 5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions. Psychopharmacology, 1993, 112, 1-12.
4. Boyer W. F., Feighner J. P.: A placebo-controlled double-blind multicenter trial of two doses of ipsapirone versus diazepam in generalized anxiety disorder. Int. Clin. Psychopharmacol., 1993, 8, 173-176.
5. Bressa G. M., Marini S., Gregori S.: Serotonin S2 receptors blockage and generalized anxiety disorders. A double-blind study on ritanserin and lorazepam. Int. J. Clin. Pharmacol. Res., 1987, 7, 111-119.
6. Ceulemans D. L., Hoppenbrouwers M. L., Gelders Y. G., Reyntjens A. J.: The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam. Pharmacopsychiatry, 1985, 18, 303-305.
7. Cook L., Davidson A. B.: Effects of behaviorally active drugs in a conflict-punishment procedure in rats. In: The Benzodiazepines. Eds. Garattini S., Mussini E., Randall L. O., Raven Press, New York, 1973, 379-404.
8. 3 receptor antagonists. Pharmacol. Toxicol., 1992, 70, 157-162.
9. Csanalosi I., Schweizer E., Case W. G., Rickels K.: Gepirone in anxiety: a pilot study. J. Clin. Psychopharmacol., 1987, 7, 31-33.
10. Cutler N. R., Sramek J. J., Keppel Hesselink J. M., Krol A., Roeschen J., Rickels K., Schweizer E.: A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial. J. Clin. Psychopharmacol., 1993, 13, 429-437.
11. Cutler N. R., Sramek J. J., Wardle T. S., Hesselink J. M., Roeschen J. K.: The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial. Psychopharmacol. Bull., 1993, 29, 303-308.
12. den Boer J. A., Westenberg H. G.: Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology, 1990, 102, 85-94.
13. Gardner C. R.: Recent developments in 5HT-related pharmacology of animal models of anxiety. Pharmacol. Biochem. Behav., 1986, 24, 1479-1485.
14. 3 receptor antagonists: a critical update on therapeutic potential. Trends Pharmacol. Sci., 1993, 14, 265-270.
15. Griebel G.: 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol. Ther., 1995, 65, 319-395.
16. Griebel G., Moreau J.-L., Jenck F., Martin J. R., Misslin R.: Some critical determinants of the behaviour of rats in the elevated plus-maze. Behav. Process., 1993, 29, 37-47.
17. Griez E., Pols H., Lousberg H.: Serotonin antagonism in panic disorder: an open trial with ritanserin. Acta Psychiat. Belg., 1988, 88, 372-377.
18. Handley S. L.: 5-Hydroxytryptamine pathways in anxiety and its treatment. Pharmacol. Ther., 1995, 66, 103-148.
19. Handley S. L., McBlane J. W.: An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs. J. Pharmacol. Toxicol. Method., 1993, 29, 129-138.
20. Handley S. L., McBlane J. W.: 5-HT drugs in animal models of anxiety. Psychopharmacology, 1993, 112, 13-20.
21. Handley S. L., McBlane J. W.: Serotonin mechanisms in animal models of anxiety. Braz. J. Med. Biol. Res., 1993, 26, 1-13.
22. Handley S. L., McBlane J. W., Critchley M. A., Njung'e K.: Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors. Behav. Brain Res., 1993, 58, 203-210.
23. Hartig P. R.: Molecular biology of 5-HT receptors. Trends Pharmacol. Sci., 1989, 10, 64-69.
24. 1 recognition sites. J. Recept. Res., 1988, 8, 59-81.
25. Hoyer D., Clarke D. E., Fozard J. R., Hartig P. R., Martin G. R., Mylecharane E. J., Saxena P. R., Humphrey P. P. A. : VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 1994, 46, 157-204.
26. 1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus. A pharmacological characterization. Naunyn-Schmied. Arch. Pharmacol., 1989, 339, 252-258.
27. Hughes R. N.: Effects on open-field behavior of diazepam and buspirone alone and in combination with chronic caffeine. Life Sci., 1993, 53, 1217-1225.
28. Iversen S. D.: 5-HT and anxiety. Neuropharmacology, 1984, 23, 1553-1560.
29. Lecrubier Y., Puech A. J., Azcona A., Bailey P. E., Lataste X.: A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder. Psychopharmacology, 1993, 112, 129-133.
30. McBlane J. W., Handley S. L.: Effects of two Stressors on behaviour in the elevated X-maze: preliminary investigation of their interaction with 8-OH-DPAT. Psychopharmacology, 1994, 116, 173-182.
31. Murphy D. L., Brooks A., Aulakh C., Pigott T. A.: Anxiolytic effects of drugs acting on 5-HT receptor subtypes. In: Serotonin, from Cell Biology to Pharmacology and Therapeutics. Eds. Vanhoutte P. M., Saxena P. R., Paoletti R., Brunello N., Jackson A. S., Kluwer Academic Publishers, Dordrecht, 1993, 223-230.
32. Pecknold J. C., Luthe L., Scott Fleury M. H., Jenkins S.: Gepirone and the treatment of panic disorder: an open study. J. Clin. Psychopharmacol., 1993, 13, 145-149.
33. Sacchetti E., Zerbini O., Banfi F., Tansella M.: Overlap of buspirone with lorazepam, diazepam and bromazepam in patients with generalized anxiety disorder: findings from a controlled, multicentre, double-blind study. Hum. Psychopharmacol. Clin. Exp., 1994, 9, 409-422.
34. 1A receptor ligands in animal models of anxiety, impulsivity and depression: multiple mechanisms of action? Prog. NeuroPsychopharmacol. Biol. Psych., 1993, 17, 87-104.
35. 3 Antagonists and Benzodiazepines, Their Comparative Behavioural Pharmacology. Eds. Rodgers R. J., Cooper S. J., John Wiley & Sons, Chichester, 1991, 365-376.
36. 1A receptor agonists and L-5-HTP in Montgomery's conflict test. Pharmacol. Biochem. Behav., 1989, 32, 259-265.
37. 2 antagonist MDL 11,939 in patients with generalized anxiety disorder. J. Clin. Psychopharmacol., 1995, 15, 20-22.
38. 3 Antagonists and Benzodiazepines. Their Comparative Behavioural Pharmacology. Eds. Rodgers R. J., Cooper S. J., John Wiley & Sons, Chichester, 1991, 107-131.
39. Westenberg H. G. M., Den Boer J. A.: Serotonin in anxiety related disorders. In: Serotonin, from Cell Biology to Pharmacology and Therapeutics. Eds. Vanhoutte P. M., Saxena P. R., Paoletti R., Brunello N., Jackson A. S., Kluwer Academic Publishers, Dordrecht, 1993, 249-254.
40. Westenberg H. G. M., Den Boer J. A.: Serotonergic basis of panic disorder. In: Psychopharmacology of Panic, Oxford University Press, Oxford, 1993, 91-109.